These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 6247719

  • 1. The Dunning tumors.
    Lubaroff DM, Canfield L, Reynolds CW.
    Prog Clin Biol Res; 1980; 37():243-63. PubMed ID: 6247719
    [Abstract] [Full Text] [Related]

  • 2. An animal model for the study of prostate carcinoma.
    Lubaroff DM, Canfield L, Rasmussen GT, Reynolds CW.
    Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781
    [Abstract] [Full Text] [Related]

  • 3. The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
    Isaacs JT, Yu GW, Coffey DS.
    Invest Urol; 1981 Jul; 19(1):20-3. PubMed ID: 7251319
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Experience with an animal model for the study of prostatic carcinoma.
    Lubaroff DM, Culp DA.
    Trans Am Assoc Genitourin Surg; 1977 Jul; 69():72-7. PubMed ID: 617916
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors.
    Halin S, Wikström P, Rudolfsson SH, Stattin P, Doll JA, Crawford SE, Bergh A.
    Cancer Res; 2004 Aug 15; 64(16):5664-71. PubMed ID: 15313905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J, Reile H, Halmos G, Groot K, Schally AV.
    Cancer Res; 1994 Jan 01; 54(1):169-74. PubMed ID: 7903203
    [Abstract] [Full Text] [Related]

  • 11. Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma.
    Coffey DS, Smolev J, Heston WD, Scott WW.
    Natl Cancer Inst Monogr; 1978 Dec 01; (49):289-91. PubMed ID: 748782
    [Abstract] [Full Text] [Related]

  • 12. Actin filament organization of the Dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential.
    Zachary JM, Cleveland G, Kwock L, Lawrence T, Weissman RM, Nabell L, Fried FA, Staab EV, Risinger MA, Lin S.
    Cancer Res; 1986 Feb 01; 46(2):926-32. PubMed ID: 3940653
    [Abstract] [Full Text] [Related]

  • 13. A novel immunological model for the study of prostate cancer.
    Sharma N, Luo J, Kirschmann DA, O'Malley Y, Robbins ME, Akporiaye ET, Lubaroff DM, Heidger PM, Hendrix MJ.
    Cancer Res; 1999 May 15; 59(10):2271-6. PubMed ID: 10344727
    [Abstract] [Full Text] [Related]

  • 14. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM, Milholland RJ, Rosen F.
    Cancer Res; 1980 Jul 15; 40(7):2188-93. PubMed ID: 7388787
    [Abstract] [Full Text] [Related]

  • 15. Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model.
    Mohler JL, Partin AW, Isaacs JT, Coffey DS.
    Cancer Res; 1988 Aug 01; 48(15):4312-7. PubMed ID: 3390827
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer.
    Smolev JK, Heston WD, Scott WW, Coffey DS.
    Cancer Treat Rep; 1977 Aug 01; 61(2):273-87. PubMed ID: 872132
    [Abstract] [Full Text] [Related]

  • 17. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF.
    Gretzer MB, Chan DW, van Rootselaar CL, Rosenzweig JM, Dalrymple S, Mangold LA, Partin AW, Veltri RW.
    Prostate; 2004 Sep 01; 60(4):325-31. PubMed ID: 15264244
    [Abstract] [Full Text] [Related]

  • 18. A metastatic human prostate cancer model using intraprostatic implantation of tumor produced by PC-3 neolacZ transfected cells.
    Tsingotjidou AS, Ahluwalia R, Zhang X, Conrad H, Emmanouilides C.
    Int J Oncol; 2003 Dec 01; 23(6):1569-74. PubMed ID: 14612928
    [Abstract] [Full Text] [Related]

  • 19. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A, Westin P, Bergh A, Cajander S, Damber JE.
    Cancer Res; 1994 Jul 01; 54(13):3594-601. PubMed ID: 8012987
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
    Sestili MA, Norris JS, Smith RG.
    Cancer Res; 1983 May 01; 43(5):2167-75. PubMed ID: 6299542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.